GBM150 GBM Model
GBM150 PDX model is a fundamental asset in preclinical Brain Cancer drug discovery, offering essential insights for treatment development. Its ability to faithfully replicate patient responses empowers researchers to tailor therapies to individual patient needs, advancing the quest for safer and more effective Brain Cancer treatments. By serving as a reliable representation of patient outcomes, GBM150 PDX plays a pivotal role in accelerating the translation of discoveries from the laboratory to clinical success.
Model Details
Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM150
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes
GBM150 Survival
Survival of orthotopic intracranial implanted GBM150 in Nu/Nu mice (n=5)
